If this message is not displayed correctly, click here.



No 165, November 2018


Editor in Chief: María José Soler Romeo
Editorial Secretariat: Valentina Cocchi, Francesca Trebelli
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters - Via XXIV Maggio, 38 - 43123 Parma - Italy

Support EKHA’s proposal for the EU Thematic Networks of 2019

Every year, the European Commission’s Health Policy Platform hosts 3 Thematic Networks, led by stakeholders. These temporary networks have the ultimate aim of producing a Joint Statement (policy recommendations for the EC). The ERA-EDTA is pleased to inform you that EKHA’s proposal for a Thematic Network on ‘Improving Organ Donation and Transplantation in the EU’ has been shortlisted by the European Commission!

The health stakeholder community has the opportunity to log in and vote online for their favourite thematic network through the Health Policy Platform. The 3 proposals that receive the highest number of votes will be considered the winners and will become the Thematic Networks of 2019. Please spread the word and participate in this vote to help EKHA make it to the final 3 selected!

Access the poll by December 6, 2018 and select "Improving Organ Donation and Transplantation in the EU led by European Kidney Health Alliance (EKHA)”.

Before casting your vote, please read the instructions on how to log-in to the Commission’s health policy portal.

Get ready for the European Certificate Examination in Nephrology 2019!

UEMS Renal Section and Boards, and the ERA-EDTA Council are pleased to announce the European Certificate Examination in Nephrology to be held on February 27, 2019. The aim of this exciting development is to further unify nephrology training across Europe.

Applications for the 2019 examination will be accepted between November 7, 2018 and December 5, 2018.

Useful papers with practical information and important hints have been recently published in NDT and CKJ: The European Certificate in Nephrology: what is involved and how to prepare and The European Certificate in Nephrology: towards harmonization and excellence in training.

Read more→

Rare Kidney Disease Webinars

The ERA-EDTA Working Group on Inherited Kidney Diseases (WGIKD) and ERKNet, the European Reference Network for Rare Kidney Diseases are happy to present Rare Kidney Disease Webinars, an educational initiative that is freely accessible to all users.


A new Webinar will be held on TUESDAY, November 27, 2018 from 4:00 to 5:00 pm CET (3:00 pm UK time, 5:00 pm Eastern European time).

Jack Wetzels (Nijmegen, Netherlands) will give a presentation on ‘Membranous Nephropathy’.

Register here to receive the access link to the Webinar.
Please pay attention to the technical requirements provided with the access link.

If you would like to be notified automatically about future Rare Kidney Disease Webinars, please sign up here for the ERKNet Newsletter.
You can find the schedule for upcoming Webinars and past presentations at www.erknet.org under the ‘Education & Training’ tab.

The challenge of osteoporosis in CKD
Do not miss this important educational session!

Join The challenge of osteoporosis in CKD educational event organised by EUROD, a CKD-MBD Working Group initiative, in collaboration with the International Osteoporosis Foundation (IOF) to be held on January 18, 2019 in Leuven (Belgium). Updates on the clinical assessment and treatment of osteoporosis in CKD anno 2019 will be presented through state of the art lectures given by key opinion leaders and the interactive voting system encouraging discussion.

Click here to download the full programme.

Click here to register.

NDT - Article of the week
Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic?
Recent pre-clinical and clinical studies suggested that sildenafil could be a promising new treatment for pre-eclampsia. In July 2018, the lead investigator of the Dutch arm of the Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction (STRIDER) trial reported increased mortality and pulmonary hypertension in newborn babies treated with sildenafil, compared with placebo.
The papers is accessible free of charge until this Sunday at 23.59 (UK time). Do not miss it!

Read more→
Just published online: read the latest CKJ article
Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
C1q/tumour necrosis factor-related protein 1 (CTRP1) is a new adipokine with multiple vascular and metabolic effects which may play a role in modulating the association between obesity and vascular disease. A recently published study looked at the link between CTRP1, obesity and CKD progression. The authors show that CTRP1 levels are higher in obese as opposed to non-obese patients with CKD. High CTRP1 levels were associated with slower kidney disease progression in a model adjusted for obesity, albuminuria, renal function and aspirin. Further studies are necessary to explore the potential renoprotective role of CTRP1.

Read more→
Contact Us
Web Site



Working Groups

...and their latest initiatives:




The advantages of being a member of ERA-EDTA

As a member you will become part of one of the
most influential European Medical Associations!


The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003.